CNFRX Performance — Columbia Bond Fund, Institutional 2 Class
Data updated: 2026-03-27
CNFRX returned +0.23% year to date and +7.75% over one year to Jan 2026. Annualised returns are +4.63% over 3 years and +0.06% over 5 years. The fund beat its Intermediate Core Bond category average: $100 invested three years ago grew to $115, against $113 for the category, and to $108 over one year, against $107. Volatility over the past three years was 6.32% a year. In the 12 months to Jan 2026 the fund took in a net $386.5M, and assets reached $1.40B.
CNFRX Growth of $100
What $100 invested in Columbia Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Core Bond category average over the same months.
| Period | CNFRX | Category average |
|---|---|---|
| 1 year (Feb 2025 – Jan 2026) | $108 | $107 |
| 3 years (Feb 2023 – Jan 2026) | $115 | $113 |
| 5 years (Feb 2021 – Jan 2026) | $100 | $101 |
| Since data start (Aug 2019 – Jan 2026) | $112 | $111 |
CNFRX Trailing Returns
Total returns to Jan 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.23% |
| 1 year | +7.75% |
| 3 years (annualised) | +4.63% |
| 5 years (annualised) | +0.06% |
CNFRX Annual Returns
Calendar-year total returns of Columbia Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jan) | +0.23% |
| 2025 | +8.08% |
| 2024 | +2.82% |
| 2023 | +7.21% |
| 2022 | −15.47% |
| 2021 | −0.73% |
| 2020 | +9.34% |
| 2019 (Aug–Dec) | +2.01% |
CNFRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.2% | — | — | — | — | — | — | — | — | — | — | — |
| 2025 | +0.5% | +2.4% | +0.1% | +0.9% | −0.8% | +1.7% | −0.3% | +1.4% | +0.9% | +0.6% | +0.6% | −0.1% |
| 2024 | +0.3% | −1.3% | +0.9% | −2.6% | +1.8% | +1.2% | +2.7% | +1.7% | +1.5% | −2.9% | +1.1% | −1.5% |
| 2023 | +4.2% | −2.6% | +2.4% | +0.5% | −1.1% | −0.5% | +0.1% | −0.5% | −2.6% | −1.9% | +5.1% | +4.2% |
| 2022 | −2.1% | −1.1% | −3.4% | −3.8% | +0.4% | −2.1% | +2.4% | −2.7% | −5.2% | −2.3% | +3.9% | −0.4% |
| 2021 | −0.1% | −1.1% | −0.7% | +0.8% | +0.4% | +0.4% | +1.0% | −0.2% | −0.9% | −0.4% | +0.4% | −0.4% |
| 2020 | +2.0% | +1.7% | −5.2% | +3.5% | +1.6% | +1.9% | +1.9% | −0.1% | +0.3% | −0.2% | +1.4% | +0.5% |
| 2019 | — | — | — | — | — | — | — | +2.6% | −0.7% | +0.4% | 0.0% | −0.2% |
CNFRX Risk
Risk measures from monthly returns over Feb 2023 – Jan 2026.
- 3-year volatility (annualised): 6.32%
- 3-year Sharpe ratio: 0.02 (vs 4.5% risk-free rate)
- Best month: +5.12% (Nov 2023)
- Worst month: −2.87% (Oct 2024)
CNFRX Fund Flows
Monthly money in and out of Columbia Bond Fund, from SEC Form N-PORT.
- 12-month net flow: $386.5M
- 12-month gross sales (incl. reinvestments): $560.8M
- Sales ÷ redemptions: 3.22×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jan 2026 | $20.0M | $10.8M | $9.2M |
| Dec 2025 | $30.2M | $9.9M | $20.4M |
| Nov 2025 | $22.3M | $14.5M | $7.8M |
| Oct 2025 | $17.6M | $14.2M | $3.4M |
| Sep 2025 | $14.2M | $24.4M | −$10.1M |
| Aug 2025 | $357.6M | $7.5M | $350.1M |
| Jul 2025 | $37.1M | $5.4M | $31.7M |
| Jun 2025 | $12.5M | $6.3M | $6.1M |
| May 2025 | $10.3M | $40.4M | −$30.1M |
| Apr 2025 | $13.3M | $18.1M | −$4.8M |
| Mar 2025 | $13.3M | $12.8M | $511K |
| Feb 2025 | $12.4M | $10.1M | $2.3M |
CNFRX Assets Under Management
Net assets of Columbia Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-01-31 | $1.40B |
| 2025-10-31 | $1.37B |
| 2025-07-31 | $1.00B |
| 2025-04-30 | $998.36M |
| 2025-01-31 | $977.19M |
| 2024-10-31 | $917.60M |
| 2024-07-31 | $892.77M |
| 2024-04-30 | $844.60M |
| 2024-01-31 | $861.99M |
| 2023-10-31 | $859.73M |
| 2023-07-31 | $951.88M |
| 2023-04-30 | $960.89M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.